Synergy Innovation Co., Ltd.
Research Synergy Innovation Co., Ltd. (048870.KQ) on Bullrun: market cap KRW 130.49B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker048870.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 130.49B
- Financial periodQ2 2026
- RevenueKRW 31.41B
- Net incomeKRW 5.23B
- Free cash flowKRW 725.63M
- Gross margin45.2%
Valuation Snapshot
latest market cap is KRW 130.49B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 130.49B | n/a | n/a | n/a |
Dividend history
About Synergy Innovation Co., Ltd.
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation universal transport solutions (SI-UTS); and invests and develops in various fields comprising microorganism, bacteria, and virus. The company also provides pharmaceutical formulations; and develops non-vascular stents.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Synergy Innovation Co., Ltd.'s market cap?
Synergy Innovation Co., Ltd.'s market capitalization is KRW 130.49B.
What does Synergy Innovation Co., Ltd. do?
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation universal transport solutions (SI-UTS); and invests and develops in various fields comprising microorganism, bacteria, and virus. The company also provides pharmaceutical formulations; and develops non-vascular stents. Synergy Innovation Co., Ltd.